Professor of Psychiatry
University of Cincinnati
Dr. Strawn is a tenured Professor of Psychiatry, Pediatrics, and Clinical Pharmacology at the University of Cincinnati. He is the Director of the UC Anxiety Disorders Research Program and the Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience at the University of Cincinnati.
His research focuses on anxiety disorders, risk factors for these conditions, and pharmacologic treatment of these disorders. His research has been funded by the National Institute of Mental Health, the National Institute of Environmental Health Sciences, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Patient Centered Outcomes Research Institute. With his collaborators, Dr. Strawn uses neuroimaging, pharmacogenetics, and pharmacologic approaches to identify early predictors of treatment response and medication tolerability in anxiety and related disorders. His work aims to determine the best treatments for individual patients based on patient-specific characteristics and to characterize the trajectory of improvement. This work has provided a platform for refining treatment targets and identifying treatment response biomarkers in anxiety and related disorders.
Dr. Strawn has authored more than 220 peer-reviewed publications and co-authored four textbooks on the treatment of children and adolescents and contemporary psychotherapy as well as psychopharmacology. He is a distinguished fellow of the American Academy of Child & Adolescent Psychiatry and has received multiple awards for teaching, mentorship, and research.
Disclosure(s): Abbvie: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, September 29, 2022); Cerevel: Consultant/Advisory Board (Ongoing); Intracellular Therapeutics: Consultant/Advisory Board (Terminated, January 6, 2022); Myriad: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Thursday, March 28, 2024
11:00 AM – 12:00 PM MDT